Sorting out the new HSV type specific antibody tests

Sexually Transmitted Infections

Volumn 77, Issue 4, 2001, Pages 232-237

  Ashley, R L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Herpes; Serology

Indexed keywords

ANTIGEN; THROMBOSPONDIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ACCURACY; ANTIBODY DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNOBLOTTING; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROLOGY; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; BENCHMARKING; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DRUG APPROVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREGNANCY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VIRAL ENVELOPE PROTEINS;

EID: 0034921526     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.77.4.232     Document Type: Review

References (66)

1. HSV type specific antibody tests: Patients are ready, are clinicians?
2. Patient attitudes to type specific serologic tests in the diagnosis of genital herpes
3. Sexually transmitted infections
4. Genital herpes: Review of the epidemic and potential use of type- specific serology
5. Testing for herpes simplex virus type 2. Full-steam ahead?
6. Public health strategies to prevent genital herpes: Where do we stand?
7. HSV-2 specific serology should be offered routinely to antenatal patients
8. Genital herpes and public health: Addressing a global problem
9. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures
10. Serological prevalence of herpes simplex virus type 2 amongst GUM clinic attenders in a district general hospital setting
11. A prospective study of new infections with herpes simplex virus type 1 and type 2
12. The management of pregnancies complicated by genital infections with herpes simplex virus
13. The acquisition of herpes simplex virus during pregnancy
14. From epidemiological synergy to public health policy and practice; the contribution of other sexually transmitted diseases to transmission of HIV infection
15. Herpes simplex type 2 infection in the developing world. Is it time to address this disease?
16. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: Frequency, patterns, and risk factors
17. Prevention agenda for genital herpes
18. Type-specific serological testing for herpes simplex infection
19. Asymptomatic herpes simplex virus shedding and Russian roulette
20. Should we be screening for asymptomatic HSV infections?
21. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes
22. New therapies and prevention strategies for genital herpes
23. Psychosocial impact of type-specific herpes simplex serological testing on asymptomatic sexual health clinic attendees
24. Type-specific antibodies to HSV-1 and -2: Review of methodology
25. Serologic analysis of first-episode non-primary genital herpes simplex virus infection
26. Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera
27. Use of densitometric analysis for interpreting HSV serologies based on western blot
28. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts
29. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" HSV-2 infection
30. Risk factors for the sexual transmission of genital herpes
31. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections
32. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy
33. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations - Relevance for the incidence of genital herpes
34. Detection of herpes simplex virus type 2- specific antibody with glycoprotein G
35. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies
36. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world
37. A seroepidemiology survey of the prevalence of herpes simplex virus 2 infection in the United States
38. Herpes simplex virus type 2 in the United States, 1976 to 1994
39. Monoclonal antibody blocking tests for the detection of HSV-1 and HSV-2 specific humoral responses: Comparison with Western blot assay
40. A monoclonal blocking EIA for herpes simplex virus type 2 (HSV-2) antibody: Validation for seroepidemiological studies in Africa
41. The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes
42. British co-operative clinical group national survey on diagnostic issues surrounding genital herpes
43. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2)
44. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens
45. Decline of herpes simplex virus type 2 and chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern
46. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies
47. Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G
48. An evaluation of near patient tests for detecting herpes simplex virus type-2 antibody
49. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies
50. Use of a gG-based type-specific assay to detect antibodies to herpes simplex virus type-2 among persons attending STD clinics
51. Comparison of four enzyme immunoassays with a Western blot assay for the determination of type-specific antibodies to herpes simplex virus
52. Evaluation of three glycoprotein G2- based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera
53. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies
54. Evaluation of a novel point of care test for antibodies to herpes simplex virus type 2
55. Premarket evaluation of the POCkit HSV-2 type- specific serologic test in culture-documented cases of genital herpes simplex virus type 2
56. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum
57. An evaluation of a new commercial HSV2 IgG antibody test (MRL)
58. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection
59. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease
60. First episodes of genital herpes in a Swedish STD population: A study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology
61. Herpes simplex virus type 1 as a cause of genital herpes: Impact on surveillance and prevention
62. Evaluation of glycoprotein G-based enzyme-linked immunosorbent assays (gG ELISA) for type-specific antibodies to herpes simplex virus type 1 and type 2 in HIV-positive and HIV-negative children and adolescents
63. Limits in the reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2
64. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy
65. Long-term HSV-2 serostatus by Western blot (WB) and Gull gG ELISA
66. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 or 2